106.34
2.71%
+2.81
ICU Medical, Inc. stock is currently priced at $106.34, with a 24-hour trading volume of 359.36K.
It has seen a +2.71% increased in the last 24 hours and a +8.60% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $103.2 pivot point. If it approaches the $108.0 resistance level, significant changes may occur.
Previous Close:
$103.53
Open:
$103.77
24h Volume:
359.36K
Market Cap:
$2.59B
Revenue:
$2.26B
Net Income/Loss:
$-29.66M
P/E Ratio:
-90.89
EPS:
-1.17
Net Cash Flow:
$72.53M
1W Performance:
+4.58%
1M Performance:
+8.60%
6M Performance:
+21.17%
1Y Performance:
-39.20%
ICU Medical, Inc. Stock (ICUI) Company Profile
Name
ICU Medical, Inc.
Sector
Industry
Phone
949-366-2183
Address
951 Calle Amanecer, San Clemente, CA
ICU Medical, Inc. Stock (ICUI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Nov-08-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mar-31-20 | Upgrade | CJS Securities | Market Perform → Market Outperform |
Mar-18-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
Aug-08-19 | Downgrade | Raymond James | Strong Buy → Outperform |
Oct-17-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
Jun-20-17 | Downgrade | Sidoti | Buy → Neutral |
Mar-11-16 | Initiated | Gabelli & Co | Buy |
Nov-06-15 | Reiterated | ROTH Capital | Buy |
Aug-11-15 | Reiterated | ROTH Capital | Buy |
May-06-15 | Reiterated | ROTH Capital | Buy |
Feb-10-15 | Reiterated | ROTH Capital | Buy |
Nov-11-14 | Upgrade | ROTH Capital | Neutral → Buy |
May-09-13 | Downgrade | The Benchmark Company | Buy → Hold |
Sep-27-12 | Reiterated | The Benchmark Company | Buy |
Apr-12-12 | Initiated | The Benchmark Company | Buy |
Sep-26-11 | Reiterated | Ticonderoga | Buy |
Oct-29-09 | Initiated | C.K. Cooper | Buy |
Oct-08-09 | Initiated | Roth Capital | Hold |
Mar-05-09 | Initiated | Northland Securities | Outperform |
May-02-08 | Initiated | Jesup & Lamont | Buy |
Mar-26-08 | Initiated | Soleil | Buy |
View All
ICU Medical, Inc. Stock (ICUI) Latest News
Midday Stock Roundup: Mullen Auto Rises 19% After Naming New EMEA VP - Orange County Business Journal
Orange County Business Journal
Insider Sale: Christian Voigtlander Sells 12,539 Shares of ICU Medical Inc (ICUI) - Yahoo Finance UK
Yahoo Finance UK
Insider Sale: Christian Voigtlander Sells 12,539 Shares of ICU Medical Inc (ICUI) - Yahoo Canada Finance
Yahoo Canada Finance
Insider Sale: Christian Voigtlander Sells 12,539 Shares of ICU Medical Inc (ICUI) By GuruFocus - Investing.com Canada
Investing.com Canada
ICU Medical, Inc. (NASDAQ:ICUI) COO Sells $1,303,429.05 in Stock - MarketBeat
MarketBeat
ICU Medical COO sells over $1.3 million in company stock By Investing.com - Investing.com
Investing.com
ICU Medical, Inc. Stock (ICUI) Financials Data
ICU Medical, Inc. (ICUI) Revenue 2024
ICUI reported a revenue (TTM) of $2.26 billion for the quarter ending December 31, 2023, a -0.92% decline year-over-year.
ICU Medical, Inc. (ICUI) Net Income 2024
ICUI net income (TTM) was -$29.66 million for the quarter ending December 31, 2023, a +60.08% increase year-over-year.
ICU Medical, Inc. (ICUI) Cash Flow 2024
ICUI recorded a free cash flow (TTM) of $72.53 million for the quarter ending December 31, 2023, a +144.92% increase year-over-year.
ICU Medical, Inc. (ICUI) Earnings per Share 2024
ICUI earnings per share (TTM) was -$1.23 for the quarter ending December 31, 2023, a +60.58% growth year-over-year.
About ICU Medical, Inc.
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV solutions, such as normal salines, ringers, etc., which are used to replenish fluids and electrolytes; irrigation solutions to hydrate the wound, remove deep debris, assist with visual examination, to prevent infection, and improve healing; and nutritional solutions that feed vitamins, minerals, and other natural therapeutic substances directly into the blood stream. In addition, the company offers infusion pumps under the Plum 360, LifeCare PCA, SapphirePlus, and Sapphire names; Cogent 2-in-1 and LiDCO LX1 hemodynamic monitoring systems; CardioFlo hemodynamic monitoring sensors; TriOx PICC invasive venous oximetry sensors; SafeSet closed blood sampling and conservation systems; Transpac consumable blood pressure transducers; and Q2 Plus continuous cardiac output/oximetry systems. The company sells its products primarily to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Cap:
|
Volume (24h):